MARKETS
Markets

QT Imaging Receives Israeli Regulatory Approval For Breast Acoustic CT Scanner Through February 2, 2028

Jul 28, 2026 · 08:36 AM ET· updated 2h ago

Regulatory approval enables commercialization of QT Imaging's technology in Israel and supports expansion of clinical research collaborationsQT Imaging Holdings, Inc.(NASDAQ:QTI) ("QT Imaging" or the

Share
Why It Matters

QT Imaging got permission from Israel to sell a special scanner that uses sound waves to check for breast cancer. This is good news because it lets them sell their product in a new country and do more research, which shows their technology is working.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.